Annual report pursuant to Section 13 and 15(d)

Statement of Cash Flows

v3.21.1
Statement of Cash Flows
6 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (8,038,450)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrant liabilities 7,852,813
Changes in operating assets and liabilities:  
Prepaid expenses (228,465)
Accounts payable 135,648
Net cash used in operating activities (278,454)
Cash flow from investing activities  
Investment in marketable securities (243,380,833)
Net cash used in investing activities (243,380,833)
Cash flows from financing activities  
Proceeds from promissory note 100,000
Repayment of promissory note (100,000)
Proceeds from sale of units in IPO, including over-allotment, net of offering costs 236,141,972
Proceeds from sale of $11.50 exercise warrants in private placement 3,848,750
Proceeds from sale of $15 exercise warrants in private placement 151,250
Net cash provided by financing activities 244,796,972
Net increase in cash 1,137,685
Cash at beginning of period 0
Cash at end of period 1,137,685
IPO  
Cash flows from financing activities  
Proceeds from sale of private units in private placement 30,000
Private Placement  
Cash flows from financing activities  
Proceeds from sale of private units in private placement $ 4,625,000